000 03608nam a22004935i 4500
001 978-1-4614-4021-5
003 DE-He213
005 20140220082813.0
007 cr nn 008mamaa
008 120830s2013 xxu| s |||| 0|eng d
020 _a9781461440215
_9978-1-4614-4021-5
024 7 _a10.1007/978-1-4614-4021-5
_2doi
050 4 _aR895-920
072 7 _aMMPH
_2bicssc
072 7 _aMMP
_2bicssc
072 7 _aMED008000
_2bisacsh
082 0 4 _a616.0757
_223
100 1 _aAktolun, Cumali.
_eeditor.
245 1 0 _aNuclear Medicine Therapy
_h[electronic resource] :
_bPrinciples and Clinical Applications /
_cedited by Cumali Aktolun, Stanley J. Goldsmith.
264 1 _aNew York, NY :
_bSpringer New York :
_bImprint: Springer,
_c2013.
300 _aXX, 443 p. 120 illus., 62 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aLymphoma -- Leukemia -- Myeloproliferative Neoplasms -- Neuroendocrine Tumors -- Bone Metastases and Bone Pain -- Melanoma -- Brain Tumors -- Well Differentiated ThyroidCarcinomas -- Medullary Carcinoma of Thyroid -- Breast Carcinoma -- Liver Tumors-Radiomicrosphere Therapy -- Liver Tumors-Systemic Radionuclide Therapy -- Colo-rectal Carcinoma -- Pancreatic Carcinoma -- Renal Cell Carcinoma -- Prostate Carcinoma -- Radioiodine Therapy of Benign Thyroid Diseases -- Radiosynoviorthesis -- Chemistry of Therapeutic Radiopharmaceuticals -- Pretargeting: Advancing the Delivery of Therapeutic Radionuclides -- Radiobiology and Low Dose Rate Radiation Effects -- Radiation Safety Considerations for Radionuclide Therapy -- Challenges Associated with Radionuclide Therapy.
520 _aNuclear Medicine Therapy presents the state of the art in targeted radionuclide therapy, both in clinical practice and contemporary clinical investigation and trials. With contributions from an internationally-distinguished group of physicians and scientists, the book is devoted entirely to the use of nuclear medicine techniques and technology for therapy of malignant and benign diseases. Individual chapters cover the scientific principles and clinical applications of radionuclide therapy and the state of clinical trials of agents currently under investigation in the therapy of tumors involving virtually every organ system. Due to overlapping interest in techniques, indications, and clinical use, the development of radionuclide therapy attracts considerable input from other medical specialists whose collaboration is essential, including radiation and medical oncologists, hematologists, diagnostic radiologists, hepatologists, endocrinologists, and rheumatologists. And because radionuclide therapy is a rapidly evolving field of nuclear medicine, it is the aim of this volume to appeal to all specialists involved in targeted radionuclide therapy and to contribute to the standardization of the practice globally.
650 0 _aMedicine.
650 0 _aRadiology, Medical.
650 0 _aNuclear medicine.
650 0 _aRadiotherapy.
650 1 4 _aMedicine & Public Health.
650 2 4 _aImaging / Radiology.
650 2 4 _aNuclear Medicine.
650 2 4 _aDiagnostic Radiology.
650 2 4 _aRadiotherapy.
700 1 _aGoldsmith, Stanley J.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461440208
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-4021-5
912 _aZDB-2-SME
999 _c95050
_d95050